Latest Operational Update News

D3 Energy has significantly boosted its helium resource estimates in South Africa's Free State with a newly certified 14 BCF helium contingent resource at ER386, lifting combined recoverable helium to 35.6 BCF across its key permits.

JB Hi-Fi posted modest sales growth in Australia and The Good Guys during Q3 FY26, while New Zealand sales declined amid rising supplier costs and stock shortages heading into a critical trading period.

Peel Mining’s scheme of arrangement with Aeris Resources, coupled with the demerger of Spectre Metals, gains strong endorsement from an independent expert, positioning shareholders for exposure to both a copper producer and a zinc-focused explorer.

Murray Cod Australia (ASX:MCA) is raising $18.6 million through a fully underwritten entitlement offer at a steep 43% discount to last price, aiming to convert its record 3,700-tonne biomass into sales and expand processing capacity.

ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.

Viva Energy is progressing repairs at its Geelong Refinery following a fire that disrupted key units, aiming to resume near-full production by June while maintaining fuel supply.

Xstate Resources reports smooth progress at its Diona-1 well in Queensland, completing stimulation and preparing for a 14-day flow test after detecting methane gas during flowback.

Elixir Energy has completed stimulation at its Diona-1 well in Queensland’s Surat-Bowen Basin, observing encouraging gas indications ahead of flow testing. The well’s proximity to major pipeline infrastructure could accelerate commercialisation if results hold.

Botala Energy faces an ASX price query after its shares jumped from $0.055 to $0.073 amid heavy trading, prompting scrutiny over undisclosed information and continuous disclosure compliance.

RBR Group has secured $365,000 in a share placement led by major shareholder Paul Natoli to fund tender activities in Mozambique and strengthen its balance sheet amid ongoing project opportunities.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.

Green360 Technologies has kicked off commercial production of its low-carbon Eco-Clay cement alternative through a capital-light tolling agreement with Calix, while securing federal grant funding and a $4.5 million placement to fuel growth.